The Centers for Medicare & Medicaid Services (CMS) announced the upcoming launch of the “Medicare GLP-1 Bridge,” a time-limited demonstration project that will provide eligible Medicare Part D beneficiaries access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, 2027. The initiative is designed to expand affordable access to innovative, evidence-based weight-loss treatments that may improve long-term health outcomes for seniors managing obesity and related conditions. CMS Administrator Dr. Mehmet Oz stated that the demonstration aims to make these medications more affordable and accessible for Medicare beneficiaries, while supporting healthier lifestyles and reducing barriers to care. CMS will continue working with providers, pharmacies, and manufacturers ahead of the program launch and encourages beneficiaries to speak with their health care providers to determine whether a GLP-1 medication is appropriate for their care needs. Additional program details are available on the CMS website.
CMS Press Release and Fact Sheet Summaries – find all press releases and fact sheets here: https://www.cms.gov/about-cms/contact/newsroom